EPIBONE, INC.
- NEW YORK, NY 10044-0163
- epibone.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $2.6M
- Awards on record
- 4
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
EPIBONE, INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About EPIBONE, INC.
- Headquarters
- NEW YORK, NY 10044-0163
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEILVKJHJJ9MVQ6
- CAGE6ZWJ7
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $2.6M
- Awards on record
- 4
- Top funding agencies
- Department of the Air Force
Awards
FA864925P0473
Recompete 6–12 mo: Potential end Jun 1, 2027 (6 months away)REGENERATING WARFIGHTER MOBILITY WITH EB-OC- A NEXT-GENERATION LIVING OSTEOCHONDRAL GRAFT TO TREAT COMBAT-ACQUIRED OSTEOARTHRITIS
Department of Defense · Department of the Air Force
- Obligated
- $1.2M
- Period of performance
- Aug 28, 2025 – Jun 1, 2027
FA864925P0253
Completed: Period of performance ended May 23, 2025NEXT-GENERATION CRANIOFACIAL SURGERY: VALIDATING EPIBONE EB-CMF REGENERATIVE BONE GRAFTS FOR USE IN THE MAXILLA
Department of Defense · Department of the Air Force
- Obligated
- $1.2M
- Period of performance
- May 23, 2025 – May 23, 2025
FA864925P0069
Completed: Period of performance ended Apr 17, 2025SOLUTION TO PROVIDE CARTILAGE REPLACEMENT FOR LONG-TERM AND PROGRESSIVE USAGE
Department of Defense · Department of the Air Force
- Obligated
- $74.5K
- Period of performance
- Jan 14, 2025 – Apr 17, 2025
FA864924P0954
Completed: Period of performance ended Nov 19, 2024EPIBONE: SOLUTION TO PROVIDE BONE RECONSTRUCTION DUE TO BATTLEFIELD INJURY
Department of Defense · Department of the Air Force
- Obligated
- $74.9K
- Period of performance
- Aug 16, 2024 – Nov 19, 2024
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
FA864925P0473 REGENERATING WARFIGHTER MOBILITY WITH EB-OC- A NEXT-GENERATION LIVING OSTEOCHONDRAL GRAFT TO TREAT COMBAT-ACQUIRED OSTEOARTHRITIS | Department of Defense · Department of the Air Force | 541715 · AC32NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; APPLIED RESEARCH | $1.2M | Aug 28, 2025 – Jun 1, 2027 | Recompete 6–12 mo: Potential end Jun 1, 2027 (6 months away)AI brief for award FA864925P0473Bid team for the recompete of award FA864925P0473 |
FA864925P0253 NEXT-GENERATION CRANIOFACIAL SURGERY: VALIDATING EPIBONE EB-CMF REGENERATIVE BONE GRAFTS FOR USE IN THE MAXILLA | Department of Defense · Department of the Air Force | 541715 · AC32NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; APPLIED RESEARCH | $1.2M | May 23, 2025 – May 23, 2025 | Completed: Period of performance ended May 23, 2025 |
FA864925P0069 SOLUTION TO PROVIDE CARTILAGE REPLACEMENT FOR LONG-TERM AND PROGRESSIVE USAGE | Department of Defense · Department of the Air Force | 541715 · AC32NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; APPLIED RESEARCH | $74.5K | Jan 14, 2025 – Apr 17, 2025 | Completed: Period of performance ended Apr 17, 2025 |
FA864924P0954 EPIBONE: SOLUTION TO PROVIDE BONE RECONSTRUCTION DUE TO BATTLEFIELD INJURY | Department of Defense · Department of the Air Force | 541715 · AC32NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; APPLIED RESEARCH | $74.9K | Aug 16, 2024 – Nov 19, 2024 | Completed: Period of performance ended Nov 19, 2024 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 9 awards
- Total awarded
- $5,045,992
- By phase
- SBIR Phase I: 5
- SBIR Phase II: 4
- By agency
- Department of Defense: 7
- Department of Health and Human Services: 2
- Active projects
- 2 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 2 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2025: 3
- 2024: 1
- 2018: 1
- 2017: 2
- 2015: 1
- 2014: 1
Awards (most recent first)
Regenerating Warfighter Mobility with EB-OC– a Next-Generation Living Osteochondral Graft to Treat Combat-Acquired Osteoarthritis
SBIR Phase II · Department of Defense (Air Force) · 2025 · $1,249,964
Aug 28, 2025 – Jun 1, 2027
- Active
- Ends Jun 2027
Solicitation X24.7 (2024) · Topic AFX247-PCSO1
Next-generation craniofacial surgery: Validating EpiBone EB-CMF regenerative bone grafts for use in the maxilla
SBIR Phase II · Department of Defense (Air Force) · 2025 · $1,249,628
May 22, 2025 – Feb 23, 2027
- Direct to Phase II
- Active
- Ends Feb 2027
Solicitation X25.5 (2025) · Topic AFX255-DPCSO1
Solution to Provide Cartilage Replacement for Long-term and Progressive Usage
SBIR Phase I · Department of Defense (Air Force) · 2025 · $74,481
Jan 14, 2025 – Apr 17, 2025
Solicitation X24.7 (2024) · Topic AFX247-PCSO1
EpiBone: Solution to Provide Bone Reconstruction due to Battlefield Injury
SBIR Phase I · Department of Defense (Air Force) · 2024 · $74,871
Aug 16, 2024 – Nov 19, 2024
Solicitation X24.5 (2024) · Topic AFX245-PCSO1
Injectable Off-the-Shelf Cell-Based Therapy Cartilage Filler
SBIR Phase II · Department of Defense (Defense Health Agency) · 2018 · $999,921
Aug 27, 2018 – Jan 26, 2021
Solicitation 2017.1 (2017) · Topic DHA17-009
Injectable Off-the-Shelf Cell-Based Therapy Cartilage Filler
SBIR Phase I · Department of Defense (Defense Health Agency) · 2017 · $148,990
Aug 15, 2017 – Aug 14, 2018
Solicitation 2017.1 (2017) · Topic DHA17-009
Production and maintenance of tissue-engineered human osteochondral grafts
SBIR Phase I · Department of Defense (Army) · 2017 · $99,153
May 15, 2017 – Nov 14, 2017
Solicitation 2016.1 (2016) · Topic A16-049
Engineered Living Bone Grafts for Complex Craniomaxillofacial Reconstructions
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2015 · $999,300
Aug 1, 2015 – Jul 31, 2018
- Direct to Phase II
Solicitation PAR14-088 (2014) · Topic NIDCR
Cellularized bone grafts for point-of-care complex craniofacial reconstructions
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $149,684
Solicitation PA13-234 (2014) · Topic NIDCR · Research partner: Stub
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
No active exclusion on record (checked Nov 14, 2026).
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · as of Nov 14, 2026
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 14, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 14, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)PrimarySmall business under this code’s size standard
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov reports this entity as small under 1 of 2 NAICS codes. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with EPIBONE, INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
